Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Silo Pharma, Inc. is a biopharmaceutical company developing therapies for underserved neurological and psychiatric conditions, including PTSD, anxiety, fibromyalgia, and Alzheimer's disease. Its focus includes traditional drugs and psychedelic formulations like psilocybin and ketamine. The company collaborates with academic institutions, licenses proprietary technologies, and advances drug candidates through preclinical and clinical stages, aiming to address unmet medical needs with innovative delivery methods and targeted treatments.
This description was generated via AI from an annual report. Updated about 1 year ago.